SML1079

BMOV

≥95% (elemental analysis)

• Synonym(e): (SP-5-31)-bis(3-hydroxy-2-methyl-4H-pyran-4-onato-O3,O4)oxo-vanadium, Bis(maltolato)oxovanadium(IV)
• Empirische Formel (Hill-System): C₁₂H₁₀O₇V
• CAS-Nummer: 38213-69-3
• Molekulargewicht: 317.15
• UNSPSC Code: 51111800
• NACRES: NA.77
• Assay: ≥95% (elemental analysis)
• Form: powder

Eigenschaften

• Quality Segment: 100
• assay: ≥95% (elemental analysis)
• form: powder
• color: , yellow to grey to brown
• solubility: DMSO: 5 mg/mL, clear (warmed)
• storage temp.: 2-8°C
• SMILES string: [V+2]=O.O2[C-](C(=O)C(=O)C=C2)C.O1[C-](C(=O)C(=O)C=C1)C
• InChI: 1S/2C6H5O3.O.V/c2*1-4-6(8)5(7)2-3-9-4;;/h2*2-3H,1H3;;/q2*-1;;+2
• InChI key: NGWOELASSYWDDT-UHFFFAOYSA-N

Beschreibung

Biochem/physiol Actions

BMOV is a potent, orally available vanadium complex that acts as insulin mimetic. Apparently, BMOV anti-diabetic effect results from enhancement of the tyrosine-phosphorylation of insulin receptor by inhibition of the protein tyrosine phosphatase-1B (PTP-1B). In diabetic rats BMOV restores normoglycaemia without rising insulin levels. BMOV is a potent phosphatase inhibitor.

BMOV is a potent, orally available vanadium complex that acts as insulin mimetic; anti-diabetic; potent phosphatase inhibitor.

Sicherheitshinweise

• pictograms: GHS06
• signalword: Danger
• hcodes: H301
• pcodes: P264 - P270 - P301 + P310 - P405 - P501
• Hazard Classifications: Acute Tox. 3 Oral
• Lagerklasse: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable